L. Kristin Newby, M.D., will be joining Dr. Galati this evening to discuss American Heart Month, and the Go Red for Women effort to bring light to the risk factors women face with heart disease.
Dr. Newby is Professor of Medicine-Cardiology, and Director of the Biosignature Advanced Biomarker Group, and Co-Director of the Duke Cardiac Care Unit.
Dr. Newby’s general research interests include risk stratification in patients with acute and chronic coronary artery disease, discovery and application of biomarkers in the diagnosis and treatment of cardiovascular disease, and heart disease in women. Her focus on the genomic contribution to the development of coronary artery disease has informed her position as co-investigator in several ongoing projects exploring the use of RNA expression profiling, proteomics, and metabolomics for coronary event risk stratification.
At the Duke Clinical Research Institute, Dr. Newby has led clinical trials of new therapies and treatment strategies for acute coronary syndromes. She has been the principal investigator of multiple studies assessing the use of novel protein biomarkers to enhance risk stratification and guide treatment selection in cardiovascular disease, and is currently pursuing the application of genomics for this purpose. She has authored more than 200 peer-reviewed publications.